1. Cablivi injection is the first therapy for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura, a rare blood-clotting disorder.
2. Jeuveau is a new wrinkle treatment for adult patients expected to rival Allergan’s Botox.
3. A generic version of the Advair Diskus inhaler, fluticasone propionate and salmeterol inhalation powder, was approved for patients with asthma or chronic obstructive pulmonary disease.
4. The FDA approved Orthofix Medical’s M6-C artificial cervical disk for patients suffering from cervical disc degeneration.
More articles on supply chain:
10 largest medical device companies
How advanced data analytics can optimize procedural supply spend
Supply chain savings tip of the week: Optimize custom procedural trays
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
